# reload+after+2024-01-21 01:44:37.121866
address1§3891 Ranchero Drive
address2§Suite 150
city§Ann Arbor
state§MI
zip§48108
country§United States
phone§734 887 3903
website§https://www.esperion.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
fullTimeEmployees§199
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Sheldon L. Koenig', 'age': 57, 'title': 'President, CEO & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1197433, 'exercisedValue': 0, 'unexercisedValue': 137453}, {'maxAge': 1, 'name': 'Mr. Benjamin O. Looker', 'age': 41, 'title': 'General Counsel', 'yearBorn': 1982, 'fiscalYear': 2022, 'totalPay': 550350, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. JoAnne Micale Foody FACC, M.D.', 'age': 57, 'title': 'Chief Medical Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 771191, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Benjamin  Halladay M.B.A.', 'age': 37, 'title': 'Chief Financial Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Glenn P. Brame', 'age': 65, 'title': 'Chief Technical Operations Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Tiffany  Aldrich M.B.A.', 'title': 'Associate Director of Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Betty Jean Swartz', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric J. Warren R.Ph.', 'age': 51, 'title': 'Chief Commercial Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§5
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.777
priceToSalesTrailing12Months§2.8180296
currency§USD
dateShortInterest§1702598400
forwardEps§-0.34
pegRatio§-0.07
exchange§NGM
quoteType§EQUITY
shortName§Esperion Therapeutics, Inc.
longName§Esperion Therapeutics, Inc.
firstTradeDateEpochUtc§1372253400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§00314c6d-38c1-3c8e-a318-bd51d9ba1c8c
gmtOffSetMilliseconds§-18000000
targetHighPrice§22.0
targetLowPrice§2.5
targetMeanPrice§8.19
targetMedianPrice§7.0
recommendationMean§2.1
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§1.143
grossMargins§-0.33499
ebitdaMargins§-1.5107499
trailingPegRatio§None
